Melodye Campbell, APRN
Family · Bowling Green, KYNPI 1780054452
Payments from drug & device makers
Across 273 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$679
- Pfizer$616
- Lilly USA, LLC$357
- AbbVie$304
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$264
- Boehringer Ingelheim$211
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 55 | $679 |
| Pfizer | 44 | $616 |
| Lilly USA, LLC | 27 | $357 |
| AbbVie | 20 | $304 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $264 |
| Boehringer Ingelheim | 14 | $211 |
| Exact Sciences | 13 | $204 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $193 |
| GSK | 11 | $184 |
| Bayer | 11 | $165 |
| Novartis | 10 | $151 |
| Astellas Pharma US Inc | 7 | $106 |
| Axsome Therapeutics, Inc. | 6 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $77 |
| Amgen | 5 | $73 |
| Seqirus USA Inc | 1 | $65 |
| Daiichi Sankyo Inc. | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| Dynavax Technologies Corporation | 2 | $44 |
| AstraZeneca | 2 | $38 |
| Abbott | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Stryker | 1 | $28 |
| Johnson & Johnson | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $11 |
How this compares
$4,170 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 107 | $101,643 |
| FarxigaDapagliflozin Propanediol | 42 | $44,526 |
| TrulicityDulaglutide | 25 | $39,071 |
| OzempicSemaglutide | 37 | $38,758 |
| MounjaroTirzepatide | 24 | $30,924 |
| JanuviaSitagliptin Phosphate | 23 | $26,537 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $22,530 |
| JardianceEmpagliflozin | 20 | $22,050 |
| MyrbetriqMirabegron | 17 | $14,660 |
| XareltoRivaroxaban | 14 | $11,031 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $9,188 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 35 | $7,168 |
| Levothyroxine Sodium | 375 | $4,505 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 132 | $3,772 |
| Atorvastatin Calcium | 585 | $3,689 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $616 | $101,643107 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $357 | $69,99549 claims |
| AstraZenecaFarxiga, Symbicort | $38 | $47,56254 claims |
| Novo NordiskOzempic | $679 | $38,75837 claims |
| GSKTrelegy Ellipta | $184 | $22,53023 claims |
| Boehringer IngelheimJardiance | $211 | $22,05020 claims |
| Astellas Pharma US IncMyrbetriq | $106 | $14,66017 claims |
| Johnson & JohnsonXarelto | $18 | $11,03114 claims |
| AbbVieSynthroid | $304 | $1,32842 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Bowling Green
- Carrie Parrish NyekanBowling Green$55K
- Cory GearldsBowling Green$51K
- Jeannette DabitBowling Green$28K
- Shellie HardcastleBowling Green$15K
- Ashley ToweBowling Green$14K
- Ayme RowlandBowling Green$14K
- Jenna PoteetBowling Green$14K
- Jacqueline ErbseBowling Green$14K
- Krista NealBowling Green$12K
- Bonnie HillLouisa$372K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.